EYPT EyePoint, Inc.
$0.37▼ -9.59%
Healthcare
Other
Pre-market
$0.37▼ -0.19%
Oct 27, 7:58 AM ET
Volume 11.05M
Avg Volume (10D) 31.52M
Key Metrics & Fundamentals
Market Cap
$30.66M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.36 - 19.11
% vs 50 MA
-89.90%
% vs 200 MA
-96.76%
RSI-14
15.3
MACD Histogram
-0.1700
Beta (1Y vs SPY)
1.11
Free Cash Flow
-$63.55M
Gross Rev
$507,000
Gross Profit
$507,000
EBITDA
-$96.69M
COGS
$0
Operating Exp
$97.89M
Operating Income
-$97.38M
EBIT
-$97.38M
Pretax Income
-$94.47M
Net Income
-$94.47M
EPS (Diluted)
-1.09
Price & Volume History
Loading chart…
Recent News
EyePoint (EYPT) Stock Sees Fair Value Cut After Duravyu Trial Setbacks
Simply Wall St. · Oct 20, 2026 10:15 PM ET
Ocular Therapeutix Has 75% Success Probability for Axpaxli in Wet Age-Related Macular Degeneration, UBS Says
MT Newswires · Oct 20, 2026 12:03 PM ET
EyePoint's DME Study Readout a Catalyst After wAMD Trial Misses Endpoint, RBC Says
MT Newswires · Oct 20, 2026 11:14 AM ET
EyePoint halves workforce and ends Phase III trial early after endpoint miss
Clinical Trials Arena · Oct 20, 2026 7:37 AM ET
EyePoint halves workforce and ends Phase III trial early after endpoint miss
Pharmaceutical Technology · Oct 20, 2026 7:37 AM ET
Why Did EYPT, CRWV, EOSE Stocks Tumble To 52-Week Lows Today?
Stocktwits · Oct 19, 2026 10:39 PM ET
EYPT Stock Layoffs: What to Know About the Latest EyePoint Job Cuts
Barchart · Oct 19, 2026 4:58 PM ET
Top Midday Decliners
MT Newswires · Oct 19, 2026 2:47 PM ET
EyePoint Drug Trial Flop Crashes Stock. Can a Strategy Shift Save It?
Barrons.com · Oct 19, 2026 12:57 PM ET
Guggenheim Downgrades EyePoint to Neutral From Buy
MT Newswires · Oct 19, 2026 12:30 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See EYPT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.